Latest & greatest articles for screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for screening

3461. Efficacy of screening mammography: a meta-analysis

Efficacy of screening mammography: a meta-analysis Efficacy of screening mammography: a meta-analysis Efficacy of screening mammography: a meta-analysis Kerlikowske K, Grady D, Rubin S M, Sandrock C, Ernster V L Authors' objectives To determine the efficacy of screening mammography by age, number of mammographic views per screen, screening interval and duration of follow-up. Searching MEDLINE was searched from January 1966 to October 31 1993 for English language publications using the terms (...) 'breast neoplasm', 'mortality', 'mass screening' and 'female'. Reference lists in relevant papers were searched manually, and colleagues and experts were consulted for additional material. Study selection Study designs of evaluations included in the review Randomised controlled trials (RCTs) and case-control studies with at least 5 years' follow-up and a minimum of 10 breast cancer deaths, were included. Hospital based case-control studies and cohort studies without controls, were excluded. Specific

1995 DARE.

3462. Mammographic screening trials for women aged under 50: a quality assessment and meta-analysis

Mammographic screening trials for women aged under 50: a quality assessment and meta-analysis Mammographic screening trials for women aged under 50: a quality assessment and meta-analysis Mammographic screening trials for women aged under 50: a quality assessment and meta-analysis Glasziou P P, Woodward A J, Mahon C M Authors' objectives To carry out a systematic quality review and meta-analysis of all randomised trials of mammographic screening that included women under 50 years of age (...) breast cancer death) was 0.95 (95% CI, 0.77 to 1.18), a statistically non-significant reduction of 5%. There were no statistically significant differences between studies and the methods of randomisation and statistical analysis used did not affect the results. Authors' conclusions These analyses suggest little if any benefit for women under 50 years of age. The results are not explained by the quality of the trials or the radiology. We recommend that women in this age group intending to be screened

1995 DARE.

3463. Cost-effectiveness of alternative screening strategies for developmental dysplasia of the hip

Cost-effectiveness of alternative screening strategies for developmental dysplasia of the hip Cost-effectiveness of alternative screening strategies for developmental dysplasia of the hip Cost-effectiveness of alternative screening strategies for developmental dysplasia of the hip Rosendahl K, Markestad T, Lie R T, Sudmann E, Geitung J T Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Using general screening (clinical screening combined with ultrasound screening of all infants) or selective screening (clinical screening plus an ultrasound screening of infants at high risk of developing developmental dysplasia of the hip (DDH)) in the diagnosis and treatment of DDH. Type of intervention Screening, diagnosis and treatment

1995 NHS Economic Evaluation Database.

3464. Screening and treatment of asymptomatic bacteriuria of pregnancy to prevent pyelonephritis: a cost-effectiveness and cost-benefit analysis

Screening and treatment of asymptomatic bacteriuria of pregnancy to prevent pyelonephritis: a cost-effectiveness and cost-benefit analysis Screening and treatment of asymptomatic bacteriuria of pregnancy to prevent pyelonephritis: a cost-effectiveness and cost-benefit analysis Screening and treatment of asymptomatic bacteriuria of pregnancy to prevent pyelonephritis: a cost-effectiveness and cost-benefit analysis Rouse D J, Andrews W W, Goldenberg R L, Owen J Record Status This is a critical (...) abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Asymptomatic bacteriuria screening and treatment strategies in pregnant women. Type of intervention Treatment and screening. Economic study type Cost-effectiveness analysis and cost-benefit analysis. Study population

1995 NHS Economic Evaluation Database.

3465. Increasing Medicaid child health screenings: the effectiveness of mailed pamphlets, phone calls, and home visits

Increasing Medicaid child health screenings: the effectiveness of mailed pamphlets, phone calls, and home visits Increasing Medicaid child health screenings: the effectiveness of mailed pamphlets, phone calls, and home visits Increasing Medicaid child health screenings: the effectiveness of mailed pamphlets, phone calls, and home visits Selby-Harrington M, Sorenson J R, Quade D, Stearns S C, Tesh A S, Donat P L Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Medicaid child health screenings using mailed pamphlets, phone calls and home visits. Type of intervention Primary prevention - screening. Economic study type Cost-effectiveness analysis. Study population Children from birth to age 21 who are eligible for Medicaid

1995 NHS Economic Evaluation Database.

3466. Fetal heart screening in low-risk pregnancies Full Text available with Trip Pro

Fetal heart screening in low-risk pregnancies Fetal heart screening in low-risk pregnancies Fetal heart screening in low-risk pregnancies Rustico M A, Benettoni A, D'Ottavio G, Maieron A, Fischer-Tamaro I, Conoscenti G, Meir Y, Montesano M, Cattaneo A, Mandruzzato G Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical (...) assessment on the reliability of the study and the conclusions drawn. Health technology Fetal heart screening in low-risk pregnancies. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population The study population comprised pregnant women who presented none of the risk features that are indications for fetal echocardiography. Setting Community and hospital. The economic study was conducted in Trieste, Italy. Dates to which data relate Effectiveness and resource

1995 NHS Economic Evaluation Database.

3467. [Evaluation of the costs of mammographic screening programme in the city of Florence]

[Evaluation of the costs of mammographic screening programme in the city of Florence] La valutazione dei costi del programma di screening mammografico nella citta di Firenze [Evaluation of the costs of mammographic screening programme in the city of Florence] La valutazione dei costi del programma di screening mammografico nella citta di Firenze [Evaluation of the costs of mammographic screening programme in the city of Florence] Spagnolo G, Zappa M, Paci E, Giorgi D, Rosselli del Turco M (...) Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Screening programme for breast cancer detection. Type of intervention Primary prevention. Economic study type Cost-effectiveness analysis. Study population The population under study

1995 NHS Economic Evaluation Database.

3468. Screening surgeons for HIV infection: a cost-effectiveness analysis

Screening surgeons for HIV infection: a cost-effectiveness analysis Screening surgeons for HIV infection: a cost-effectiveness analysis Screening surgeons for HIV infection: a cost-effectiveness analysis Owens D, Harris R A, Scott P M, Nease R F Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment (...) on the reliability of the study and the conclusions drawn. Health technology HIV infection screening of surgeons. Type of intervention Secondary prevention, screening. Economic study type Cost-effectiveness analysis. Study population A hypothetical cohort of surgeons. Setting Hospital. The economic study was carried out in California, USA. Dates to which data relate The main effectiveness data were obtained from publications over the period 1986-1992. Cost data were estimated from data between 1989-1994.1993

1995 NHS Economic Evaluation Database.

3469. School-based screening for tuberculous infection: a cost-benefit analysis

School-based screening for tuberculous infection: a cost-benefit analysis School-based screening for tuberculous infection: a cost-benefit analysis School-based screening for tuberculous infection: a cost-benefit analysis Mohle-Boetani J C, Miller B, Halpern M, Trivedi A, Lessler J, Solomon S L, Fenstersheib M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results (...) and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Screening for tuberculous infection using Tuberculin Skin Test (TST). Type of intervention Primary prevention, treatment, and screening. Economic study type Cost-effectiveness analysis. Study population Hypothetical cohorts of children of five years of age (18,263, 7.4% of whom were in the 'high risk' group) and children of 14 years of age (15, 639, 21.9% of whom were

1995 NHS Economic Evaluation Database.

3470. A cost-effectiveness analysis of cervical cancer screening: health policy implications

A cost-effectiveness analysis of cervical cancer screening: health policy implications A cost-effectiveness analysis of cervical cancer screening: health policy implications A cost-effectiveness analysis of cervical cancer screening: health policy implications Gyrd-Hansen D, Holund B, Andersen P Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions (...) followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Cervical cancer screening programme. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Hypothetical cohort of women aged between 15 and 99 years in Denmark. Setting The economic evaluation was performed in Denmark. Dates to which data relate The effectiveness of screening data related to the period 1966 to 1982. Prices were based on 1992

1995 NHS Economic Evaluation Database.

3471. Cost-effectiveness analysis in early detection of prostate cancer: an evaluation of six screening strategies in a randomly selected population of 2,400 men

Cost-effectiveness analysis in early detection of prostate cancer: an evaluation of six screening strategies in a randomly selected population of 2,400 men Cost-effectiveness analysis in early detection of prostate cancer: an evaluation of six screening strategies in a randomly selected population of 2,400 men Cost-effectiveness analysis in early detection of prostate cancer: an evaluation of six screening strategies in a randomly selected population of 2,400 men Gustafsson O, Carlsson P (...) , Norming U, Nyman C R, Svensson H Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The early detection of prostate cancer: a cost-effectiveness analysis of six screening strategies using different combinations of digital rectal

1995 NHS Economic Evaluation Database.

3472. The impact of initiating a human immunodeficiency virus screening program in an urban obstetric population

The impact of initiating a human immunodeficiency virus screening program in an urban obstetric population The impact of initiating a human immunodeficiency virus screening program in an urban obstetric population The impact of initiating a human immunodeficiency virus screening program in an urban obstetric population Lewis R, O'Brien J M, Ray D T, Sibai B M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract (...) contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Offering voluntary routine human immunodeficiency virus (HIV) screening (an enzyme-linked immunosorbent assay (ELISA)) to all patients in a general obstetrics clinic. Type of intervention Screening and treatment. Economic study type Cost-effectiveness analysis. Study population Clinic outpatients of child bearing age

1995 NHS Economic Evaluation Database.

3473. The cost-effectiveness of mammographic screening strategies

The cost-effectiveness of mammographic screening strategies The cost-effectiveness of mammographic screening strategies The cost-effectiveness of mammographic screening strategies Lindfors K K, Rosenquist J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study (...) and the conclusions drawn. Health technology Mammographic screening for breast cancer. A total of seven strategies were considered: (1)annual mammography for ages 40 to 79 years; (2)annual mammography for ages 50 to 79 years; (3) biennial mammography for ages 50 to 79 years; (4)annual mammography for ages 40 to 49 years with biennial mammography for ages 50 to 79 years; (5)annual mammography for ages 40 to 64 years with biennial mammography for age 65 to 79 years; (6)biennial mammography for ages 40 to 49 years

1995 NHS Economic Evaluation Database.

3474. Mammographic screening of women aged 40-49 years: benefit, risk, and cost considerations

Mammographic screening of women aged 40-49 years: benefit, risk, and cost considerations Mammographic screening of women aged 40-49 years: benefit, risk, and cost considerations Mammographic screening of women aged 40-49 years: benefit, risk, and cost considerations Feig S A Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed (...) critical assessment on the reliability of the study and the conclusions drawn. Health technology Mammographic screening of women aged 40-49 and 50-59 years. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Women aged 40-59 years. Setting Hospital. The economic study was carried out in the USA. Dates to which data relate Effectiveness data were based on published studies covering the period between 1963 and 1995. Resource use data and their corresponding

1995 NHS Economic Evaluation Database.

3475. Tuberculosis screening among homeless persons with AIDS living in single-room-occupancy hotels

Tuberculosis screening among homeless persons with AIDS living in single-room-occupancy hotels Tuberculosis screening among homeless persons with AIDS living in single-room-occupancy hotels Tuberculosis screening among homeless persons with AIDS living in single-room-occupancy hotels Layton M, Cantwell M, Dorsinville G, Valway S, Onorato M, Frieden T Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains (...) a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Tuberculosis screening strategies. In particular: 1)interviewing for symptoms and tuberculosis history; 2) skin tests using the Mantoux method, and conducting anergy tests; 3) portable frontal-view radiographs. Type of intervention Screening and diagnosis. Economic study type Cost-effectiveness analysis. Study population

1995 NHS Economic Evaluation Database.

3476. Cost-benefit analysis of screening for toxoplasmosis during pregnancy

Cost-benefit analysis of screening for toxoplasmosis during pregnancy Cost-benefit analysis of screening for toxoplasmosis during pregnancy Cost-benefit analysis of screening for toxoplasmosis during pregnancy Lappalainen M, Sintonen H, Koskiniemi M, Hedman K, Hiilesmaa V, Ammala P, Teramo K, Koskela P Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results (...) and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Screening and health education versus a health education without screening option, for primary toxoplasma infections during pregnancy. Type of intervention Screening; treatment; primary prevention. Economic study type Cost-effectiveness analysis. Study population Pregnant women. Setting The practice setting was the primary care sector. The economic study was conducted

1995 NHS Economic Evaluation Database.

3477. Cost effectiveness of antenatal screening for cystic fibrosis

Cost effectiveness of antenatal screening for cystic fibrosis Cost effectiveness of antenatal screening for cystic fibrosis Cost effectiveness of antenatal screening for cystic fibrosis Cuckle H, Richardson G, Sheldon T, Quirke P Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability (...) of the study and the conclusions drawn. Health technology Sequential carrier testing (mother first then partner - if mother is found to be a carrier) and couple carrier testing (mother and partner both tested together), as strategies for antenatal screening for cystic fibrosis. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Pregnant women and their partners. Setting The economic study was carried out in Yorkshire, UK. Dates to which data relate

1995 NHS Economic Evaluation Database.

3478. Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation

Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation Daniels K, McKee M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study examined the use of faecal occult blood tests (FOBTs) to detect pre-symptomatic colorectal cancer and its precursor lesions as part of periodic medical examinations and screenings. The options were to start FOBTs at one of the following ages: 30, 35, 40, 45, 50, 55 or 60. Type of intervention Screening. Economic study type Cost-effectiveness analysis

1995 NHS Economic Evaluation Database.

3479. Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation

Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation Kiberd B A, Jindal K K Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Strategies to prevent the development of end stage renal disease. Strategy A: Early screening, testing for microalbuminuria. Two positive tests out of three (>20 micrograms/minute) were followed by treatment with an angiotensin converting enzyme inhibitor. Strategy B: No testing for microalbuminuria, same treatment as strategy A in patients with hypertension

1995 NHS Economic Evaluation Database.

3480. In search of the best upper age limit for breast cancer screening

In search of the best upper age limit for breast cancer screening In search of the best upper age limit for breast cancer screening In search of the best upper age limit for breast cancer screening Boer R, de Koning H J, van Oortmarssen G J, van der Maas P J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical (...) assessment on the reliability of the study and the conclusions drawn. Health technology Breast cancer screening for different age categories. Type of intervention Screening. Economic study type Cost-utility analysis. Study population Women undergoing breast cancer screening. Setting Hospital. The economic study was carried out in Rotterdam, the Netherlands. Dates to which data relate The main effectiveness data were extracted from previously published and unpublished studies from the period 1977 to 1991

1995 NHS Economic Evaluation Database.